GH1 and Growth delay: The majority of the centers in the current survey chose to start GH treatment when the patient with TS had evidence of growth failure, i.e., a height velocity <50th percentile observed over six months, the child was already short or had a high likelihood of short stature, which is in line with the recommendation from the current guidelines (3,4).